The International Conference on Digital Healthcare, scheduled for February 12-13, 2024, in London, UK, serves as a platform uniting academic scientists, researchers, and scholars. This conference endeavors to facilitate the exchange of experiences and research outcomes encompassing all facets of Digital Healthcare. By providing an interdisciplinary forum, it enables researchers, practitioners, and educators to showcase recent innovations, discuss emerging trends, and address practical challenges encountered in this field. With a focus on fostering collaboration, this event offers exceptional value to students, academics, and industry researchers, encompassing diverse scholarly presentations throughout its duration.
In spite of challenges in delivering RNAi therapeutics beyond the liver and scaling up manufacturing, the 5th RNAi-Based Therapeutics Summit, returning to Boston in February 2024, promises fresh insights. This event will feature a revamped pre-conference workshop highlighting innovative approaches to target untreatable areas. Leading industry figures from Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Transcode Therapeutics, Sirnaomics, and OliX Pharmaceuticals will convene to tackle key hurdles in RNAi therapy development. Through data-driven presentations and interactive sessions, this dedicated gathering aims to expedite RNAi therapeutics' journey to clinical application and approval. Scheduled from Tue, 13 Feb 2024, at 08:00 to Thu, 15 Feb 2024, at 16:00.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our